Anthony M Valeri1, Shelief Y Robbins-Juarez1, Jacob S Stevens1,2, Wooin Ahn1, Maya K Rao1, Jai Radhakrishnan1, Ali G Gharavi1, Sumit Mohan1,2,3, S Ali Husain4,2. 1. Division of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York. 2. The Columbia University Renal Epidemiology Group, New York, New York. 3. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York. 4. Division of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York SAH2134@cumc.columbia.edu.
Abstract
BACKGROUND: The relative immunosuppression and high prevalence of comorbidities in patients with ESKD on dialysis raise concerns that they may have an elevated risk of severe coronavirus disease 2019 (COVID-19), but outcomes for COVID-19 in such patients are unclear. METHODS: To examine presentation and outcomes of COVID-19 in patients with ESKD on dialysis, we retrospectively collected clinical data on 59 patients on dialysis who were hospitalized with COVID-19. We used Wilcoxon rank sum and Fischer exact tests to compare patients who died versus those still living. RESULTS: Two of the study's 59 patients were on peritoneal dialysis, and 57 were on hemodialysis. Median age was 63 years, with high prevalence of hypertension (98%) and diabetes (69%). Patients who died were significantly older than those still living (median age, 75 versus 62 years) and had a higher median Charlson comorbidity index (8 versus 7). The most common presenting symptoms were fever (49%) and cough (39%); initial radiographs most commonly showed multifocal or bilateral opacities (59%). By end of follow-up, 18 patients (31%) died a median 6 days after hospitalization, including 75% of patients who required mechanical ventilation. Eleven of those who died had advanced directives against intubation. The remaining 41 patients (69%) were discharged home a median 8 days after admission. The median initial white blood cell count was significantly higher in patients who died compared with those still living (7.5 versus 5.7×103/μl), as was C-reactive protein (163 versus 80 mg/L). CONCLUSIONS: The association of COVID-19 with high mortality in patients with ESKD on dialysis reinforces the need to take appropriate infection control measures to prevent COVID-19 spread in this vulnerable population.
BACKGROUND: The relative immunosuppression and high prevalence of comorbidities in patients with ESKD on dialysis raise concerns that they may have an elevated risk of severe coronavirus disease 2019 (COVID-19), but outcomes for COVID-19 in such patients are unclear. METHODS: To examine presentation and outcomes of COVID-19 in patients with ESKD on dialysis, we retrospectively collected clinical data on 59 patients on dialysis who were hospitalized with COVID-19. We used Wilcoxon rank sum and Fischer exact tests to compare patients who died versus those still living. RESULTS: Two of the study's 59 patients were on peritoneal dialysis, and 57 were on hemodialysis. Median age was 63 years, with high prevalence of hypertension (98%) and diabetes (69%). Patients who died were significantly older than those still living (median age, 75 versus 62 years) and had a higher median Charlson comorbidity index (8 versus 7). The most common presenting symptoms were fever (49%) and cough (39%); initial radiographs most commonly showed multifocal or bilateral opacities (59%). By end of follow-up, 18 patients (31%) died a median 6 days after hospitalization, including 75% of patients who required mechanical ventilation. Eleven of those who died had advanced directives against intubation. The remaining 41 patients (69%) were discharged home a median 8 days after admission. The median initial white blood cell count was significantly higher in patients who died compared with those still living (7.5 versus 5.7×103/μl), as was C-reactive protein (163 versus 80 mg/L). CONCLUSIONS: The association of COVID-19 with high mortality in patients with ESKD on dialysis reinforces the need to take appropriate infection control measures to prevent COVID-19 spread in this vulnerable population.
Authors: Ho Yuen Frank Wong; Hiu Yin Sonia Lam; Ambrose Ho-Tung Fong; Siu Ting Leung; Thomas Wing-Yan Chin; Christine Shing Yen Lo; Macy Mei-Sze Lui; Jonan Chun Yin Lee; Keith Wan-Hang Chiu; Tom Wai-Hin Chung; Elaine Yuen Phin Lee; Eric Yuk Fai Wan; Ivan Fan Ngai Hung; Tina Poy Wing Lam; Michael D Kuo; Ming-Yen Ng Journal: Radiology Date: 2020-03-27 Impact factor: 11.105
Authors: Antoney J Ferrey; Grace Choi; Ramy M Hanna; Yongen Chang; Ekamol Tantisattamo; Kaushik Ivaturi; Elisa Park; Lawrence Nguyen; Brian Wang; Sam Tonthat; Connie M Rhee; Uttam Reddy; Wei Ling Lau; Susan S Huang; Shruti Gohil; Alpesh N Amin; Lanny Hsieh; Timmy T Cheng; Richard A Lee; Kamyar Kalantar-Zadeh Journal: Am J Nephrol Date: 2020-03-28 Impact factor: 3.754
Authors: José Zúñiga; Néstor Toapanta; Natalia Ramos; Sonia Caparros; Juan León-Roman; María Azancot; Clara Garcia-Carro; Eugenia Espinel; Daniel Seron; María José Soler Journal: Nefrologia (Engl Ed) Date: 2021-01-28
Authors: Steven Weiss; Premila Bhat; Maria Del Pilar Fernandez; J Ganesh Bhat; George N Coritsidis Journal: J Am Soc Nephrol Date: 2020-10-19 Impact factor: 10.121
Authors: João João Mendes; José Artur Paiva; Filipe Gonzalez; Paulo Mergulhão; Filipe Froes; Roberto Roncon; João Gouveia Journal: Rev Bras Ter Intensiva Date: 2022-01-24
Authors: Lili Chan; Suraj K Jaladanki; Sulaiman Somani; Ishan Paranjpe; Arvind Kumar; Shan Zhao; Lewis Kaufman; Staci Leisman; Shuchita Sharma; John Cijiang He; Barbara Murphy; Zahi A Fayad; Matthew A Levin; Erwin P Bottinger; Alexander W Charney; Benjamin S Glicksberg; Steven G Coca; Girish N Nadkarni Journal: Clin J Am Soc Nephrol Date: 2020-10-30 Impact factor: 8.237
Authors: Dorota Zarębska-Michaluk; Jerzy Jaroszewicz; Magdalena Rogalska; Beata Lorenc; Marta Rorat; Anna Szymanek-Pasternak; Anna Piekarska; Aleksandra Berkan-Kawińska; Katarzyna Sikorska; Magdalena Tudrujek-Zdunek; Barbara Oczko-Grzesik; Beata Bolewska; Piotr Czupryna; Dorota Kozielewicz; Justyna Kowalska; Regina Podlasin; Krzysztof Kłos; Włodzimierz Mazur; Piotr Leszczyński; Bartosz Szetela; Katarzyna Reczko; Robert Flisiak Journal: J Clin Med Date: 2021-05-10 Impact factor: 4.241